Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03734055 · ClinicalTrials.gov registry record · NA

Peer Approaches to Lupus Self-management

A NA study of Quality of Life and Systemic Lupus Erythematosus, sponsored by Medical University of South Carolina.

Active
Registry status
NA
Development phase
314
Enrollment target
1
Study location

NCT03734055: Active NA study of Quality of Life and Systemic Lupus Erythematosus, sponsored by Medical University of South Carolina.

NCT03734055 is a NA study of Quality of Life and Systemic Lupus Erythematosus that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 314 participants, below the 450-participant average among 107 other Quality of Life trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03734055, a NA study of Quality of Life and Systemic Lupus Erythematosus, is active but no longer recruiting, sponsored by Medical University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
314 participants
Enrollment target
1
Study location

Study Summary

The Peer Approaches to Lupus Self-Management (PALS) study is a randomized, controlled in which 360 African American women with lupus will be recruited from the MUSC SLE database (60 mentors and 300 mentees). The peer mentoring intervention (patients will be matched with peer mentors who are considered competent in the management of their condition to provide modeling and reinforcement to participants) will occur by telephone for approximately 60 minutes every two weeks for 24 weeks. All participants will be assessed at baseline, mid-intervention (12 weeks post-enrollment), immediately following the intervention (24 weeks post-enrollment), and 12 months post-enrollment. The study will last 60 months with recruitment and enrollment over 48 months, 6 months for intervention delivery and 6 months for data analysis.

Primary Outcome

Quality of life will be assessed by using The LUP-QOL (Lupus Quality of Life Questionnaire), which assesses areas of the participant's life that may be affected by lupus. The score ranges from 0-100. A score of '0' indicates the lowest quality of life, and a score of 100 indicates the best quality of life. The 'Overall Impact' field reported has a scale of 0-700. Higher values represent a better outcome.

Interventions

  • BEHAVIORAL Peer Mentoring
  • BEHAVIORAL Social Support Group

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 314 participants
Start Date 2018-11-30
Est. Completion 2026-06-30
Phase NA

What the registry record for NCT03734055 still lists

NCT03734055 is an interventional study that assigns participants to a tested intervention. The registered 314 participants enrollment target is mid-sized for trials with a published cap, below the 450-participant average among 107 other Quality of Life trials with a reported enrollment target (30% lower).

The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 2 interventions - of which Peer Mentoring is the first listed.

NCT03734055 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT03734055 about?

NCT03734055 is a clinical study titled "Peer Approaches to Lupus Self-management". The Peer Approaches to Lupus Self-Management (PALS) study is a randomized, controlled in which 360 African American women with lupus will be recruited from the MUSC SLE database (60 mentors and 300 mentees). The peer mentoring intervention (patients will be matched with peer mentors who are consider...

What is the current status of trial NCT03734055?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 314 participants. The study started on 2018-11-30. Estimated completion is 2026-06-30.

What conditions does trial NCT03734055 study?

This clinical trial studies the following conditions: Quality of Life, Systemic Lupus Erythematosus, Behavior, Health.

What interventions are being tested in trial NCT03734055?

The interventions under investigation include: Peer Mentoring (BEHAVIORAL), Social Support Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03734055?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03734055 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03734055's enrollment target sits among peer trials

314 23rd of 107 higher than 85 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03866382 · 314 participants · Phase 2

    Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • NCT04500756 · 314 participants · Phase 2

    Limiting AAA With Metformin (LIMIT) Trial

  • NCT06167746 · 314 participants · Phase 3

    iCare4Me Transitions

  • NCT06883097 · 314 participants · NA

    Quitting Matters Human Immunodeficiency Virus Hybrid Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03734055, the US trial registry maintained by the National Library of Medicine. NCT03734055 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.